Back	Print
31/01/2008, 08.01 AM CET
Novartis files its Form 20-F annual report with the US Securities and Exchange Commission
Basel, January 31, 2008 - Novartis has filed its annual report on Form 20-F with the US Securities and Exchange Commission and has posted this document on its website at www.novartis.com. A copy of the Group's traditional annual report is also available on this website. Novartis shareholders may receive a hard copy of either of these documents, each of which contain complete audited financial statements, free of charge, upon request. Basel, January 31, 2008 - Novartis has filed its annual report on Form 20-F with the US Securities and Exchange Commission and has posted this document on its website at www.novartis.com.  A copy of the Group's traditional annual report is also available on this website.  Novartis shareholders may receive a hard copy of either of these documents, each of which contain complete audited financial statements, free of charge, upon request.                                                                                                                            # # #   Novartis Media Relations John Gilardi Novartis Global Media Relations +41 61 324 3018 (direct) +41 79 596 1408 (mobile) john.gilardi@novartis.com Brandi Robinson Novartis US Corporate Communications +1 212 830 2408 (direct) +1 212 361 9368 (mobile) brandi.robinson@novartis.com   e-mail: media.relations@novartis.com   Novartis Investor Relations International North America Ruth Metzler-Arnold Katharina Ambuehl Pierre-Michel Bringer Jason Hannon Thomas Hungerbuehler Richard Jarvis Isabella Zinck   Central phone no: +41 61 324 7944 e-mail: investor.relations@novartis.com Jill Pozarek                     +1 212 830 2445 Edwin Valeriano            +1 212 830 2456               e-mail: investor.relations@novartis.com   Attachments: Media release (PDF)